BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 1036844)

  • 1. An immunological method for detection of the carrier of hemophilia B.
    Matsuoka M; Ito M; Takahashi K; Sakuragawa N
    Thromb Haemost; 1976 Nov; 36(2):441-50. PubMed ID: 1036844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
    Thompson AR
    J Clin Invest; 1977 May; 59(5):900-10. PubMed ID: 856873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of factor IX antigen and coagulant in hemophilia B patients and carriers.
    Pechet L; Tiarks CY; Stevens J; Sudhindra RR; Lipworth L
    Thromb Haemost; 1979 Feb; 40(3):465-77. PubMed ID: 425061
    [No Abstract]   [Full Text] [Related]  

  • 4. A factor IX gene probe: its use in carrier detection, antenatal diagnosis and characterisation of the molecular basis for hemophilia B.
    Trent RJ; Svirklys L; Power PA; Rickard KA; Lammi A; Kronenberg H
    Aust N Z J Med; 1985 Dec; 15(6):721-6. PubMed ID: 3869438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH
    Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding symptoms in carriers of hemophilia A and B.
    Mauser Bunschoten EP; van Houwelingen JC; Sjamsoedin Visser EJ; van Dijken PJ; Kok AJ; Sixma JJ
    Thromb Haemost; 1988 Jun; 59(3):349-52. PubMed ID: 2847347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple inhibitor screen is more sensitive than a Bethesda assay in monitoring for the development of inhibitors in haemophilia A and B.
    Keeling D; Beavis J; Sukhu K
    Br J Haematol; 2005 Mar; 128(6):885. PubMed ID: 15755295
    [No Abstract]   [Full Text] [Related]  

  • 9. The abnormal factor IX of hemophilia B+ variants.
    Bertina RM; Veltkamp JJ
    Thromb Haemost; 1978 Oct; 40(2):335-49. PubMed ID: 734633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of carriers of haemophilia B.
    Orstavik KH; Veltkamp JJ; Bertina RM; Hermans J
    Br J Haematol; 1979 Jun; 42(2):293-301. PubMed ID: 465373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor IX Deventer-evidence for the heterogeneity of hemophilia BM.
    Bertina RM; van der Linden IK
    Thromb Haemost; 1982 Apr; 47(2):136-40. PubMed ID: 7101232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive solid phase enzyme immunoassay for factor IX antigen and classification of hemophilia B.
    Takamatsu J; Kamiya T; Ogata K; Sugihara T; Koie K; Kato K
    Haemostasis; 1983; 13(1):9-16. PubMed ID: 6341181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular diagnosis in patients and carriers of hemophilia A and B].
    Mantilla-Capacho J; Beltrán-Miranda CP; Jaloma-Cruz AR
    Gac Med Mex; 2005; 141(1):69-71. PubMed ID: 15754755
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of carrier status of hemophilia B using DNA markers.
    Ishak R; Zakaria Z
    Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):629-30. PubMed ID: 9561621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of hemophilia B carriers using two novel dinucleotide polymorphisms and Hha I RFLP of the factor IX gene in Japanese subjects.
    Toyozumi H; Kojima T; Matsushita T; Hamaguchi M; Tanimoto M; Saito H
    Thromb Haemost; 1995 Oct; 74(4):1009-14. PubMed ID: 8560402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabbit polyclonal antibodies against the calcium-dependent conformation of factor IX and their application in solid phase immunoradiometric assays.
    Poort SR; van der Linden IK; Krommenhoek-van Es C; Briët E; Bertina RM
    Thromb Haemost; 1986 Feb; 55(1):122-8. PubMed ID: 3704999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genotyping of the Italian cohort of patients with hemophilia B.
    Belvini D; Salviato R; Radossi P; Pierobon F; Mori P; Castaldo G; Tagariello G;
    Haematologica; 2005 May; 90(5):635-42. PubMed ID: 15921378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological studies on factor IX antigen in patients with hemophilia B variant].
    Fujimura Y; Takase T; Sakai T; Shima M; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):952-61. PubMed ID: 7158257
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular diagnosis of inherited coagulation disorders--sequence analysis of hemophilia B patients with anti-factor IX antibodies].
    Tanimoto M; Matsushita T; Takamatsu J; Saito H
    Rinsho Byori; 1990 Sep; 38(9):1041-6. PubMed ID: 2232265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.